Blockade of intravenous amphetamine euphoria in man - PubMed (original) (raw)
Clinical Trial
. 1971 Nov-Dec;12(6):889-96.
doi: 10.1002/cpt1971126889.
- PMID: 4944167
- DOI: 10.1002/cpt1971126889
Clinical Trial
Blockade of intravenous amphetamine euphoria in man
L E Jönsson et al. Clin Pharmacol Ther. 1971 Nov-Dec.
No abstract available
Similar articles
- Blocking effect of alpha-methyltyrosine on amphetamine based reinforcement.
Davis WM, Smith SG. Davis WM, et al. J Pharm Pharmacol. 1973 Feb;25(2):174-7. doi: 10.1111/j.2042-7158.1973.tb10616.x. J Pharm Pharmacol. 1973. PMID: 4146554 No abstract available. - Clinical trials with amphetamine-blocking drugs.
Gunne LM, Anggård E, Jönsson LE. Gunne LM, et al. Psychiatr Neurol Neurochir. 1972 May-Jun;75(3):225-6. Psychiatr Neurol Neurochir. 1972. PMID: 4402653 No abstract available. - [Amphetamine poisoning].
Gunne LM, Holmgren P, Lindquist O, Saldeen T. Gunne LM, et al. Lakartidningen. 1972 Sep 20;69(39):4373-6. Lakartidningen. 1972. PMID: 5075962 Swedish. No abstract available. - Actions of various marihuana derivatives in man.
Hollister LE. Hollister LE. Pharmacol Rev. 1971 Dec;23(4):349-57. Pharmacol Rev. 1971. PMID: 4943949 Review. No abstract available. - [Biochemical aspects on ethyl alcohol's central stimulating and euphoretic effects].
Engel J. Engel J. Lakartidningen. 1974 Mar 6;71(10):954-5. Lakartidningen. 1974. PMID: 4596796 Review. Swedish. No abstract available.
Cited by
- Effect of d- and l-amphetamine on rat plasma prolactin levels.
Meltzer HY, Fessler RG, Simonovic M, Doherty J, Fang VS. Meltzer HY, et al. Psychopharmacology (Berl). 1979 Mar 14;61(1):63-9. doi: 10.1007/BF00426812. Psychopharmacology (Berl). 1979. PMID: 108721 No abstract available. - Inhibition of the in vivo biosynthesis and changes of catecholamine levels in rat brain after alpha-methyl-p-tyrosine; time- and dose-response relationships.
Widerlöv E, Lewander T. Widerlöv E, et al. Naunyn Schmiedebergs Arch Pharmacol. 1978 Sep;304(2):111-23. doi: 10.1007/BF00495547. Naunyn Schmiedebergs Arch Pharmacol. 1978. PMID: 703854 - Behavioral functions of the mesolimbic dopaminergic system: an affective neuroethological perspective.
Alcaro A, Huber R, Panksepp J. Alcaro A, et al. Brain Res Rev. 2007 Dec;56(2):283-321. doi: 10.1016/j.brainresrev.2007.07.014. Epub 2007 Aug 21. Brain Res Rev. 2007. PMID: 17905440 Free PMC article. Review. - Dopamine and reward: the anhedonia hypothesis 30 years on.
Wise RA. Wise RA. Neurotox Res. 2008 Oct;14(2-3):169-83. doi: 10.1007/BF03033808. Neurotox Res. 2008. PMID: 19073424 Free PMC article. Review. - The dopamine augmenter L-DOPA does not affect positive mood in healthy human volunteers.
Liggins J, Pihl RO, Benkelfat C, Leyton M. Liggins J, et al. PLoS One. 2012;7(1):e28370. doi: 10.1371/journal.pone.0028370. Epub 2012 Jan 4. PLoS One. 2012. PMID: 22238577 Free PMC article. Clinical Trial.